The Departments of Pharmacology and Ophthalmology and Visual Sciences at Case Western Reserve University School of Medicine have been awarded a $10.1 million grant from the National Eye Institute (NEI) to research and develop new treatments for disease…
Category: News
Central Serous Chorioretinopathy: An Update on Pathogenesis and Treatment
How does central serous chorioretinopathy develop, and how is it best treated? Eye
Prostate Cancer Treatment May Be Tied to Cataracts
Older prostate cancer patients who opt for androgen deprivation therapy might be slightly raising their risk of developing cataracts, a new study suggests. Reuters Health Information
Adalimumab May Be Superior to Infliximab in Childhood Uveitis
In children with chronic uveitis, adalimumab appears to be more effective than infliximab in maintaining remission, according to a small cohort study by Italian investigators. Reuters Health Information
Decagonal Trephination Pattern Suggested For Penetrating Keratoplasty
A study suggested that the decagonal trephination pattern is safe and effective for penetrating keratoplasty with femtosecond laser.
FDA Issues Complete Response Letter To Alimera Sciences Regarding New Drug Application For ILUVIEN(R)
Alimera Sciences, Inc. (Nasdaq:ALIM) (“Alimera”), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it received a Complete Response Letter (C…
Decagonal Trephination Pattern Suggested For Penetrating Keratoplasty
A study suggested that the decagonal trephination pattern is safe and effective for penetrating keratoplasty with femtosecond laser.
FDA Issues Complete Response Letter To Alimera Sciences Regarding New Drug Application For ILUVIEN(R)
Alimera Sciences, Inc. (Nasdaq:ALIM) (“Alimera”), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it received a Complete Response Letter (C…
Have Cataracts? Get Surgery, Woman Urges
Marilyn Norred has known for 30 years that she had cataracts in both eyes.
Prostate Cancer Treatment May Be Tied To Cataracts
Older men who opt for hormone-blocking therapy to treat prostate cancer might be slightly raising their risk of developing cataracts, hints new research.
Have Cataracts? Get Surgery, Woman Urges
Marilyn Norred has known for 30 years that she had cataracts in both eyes.
Prostate Cancer Treatment May Be Tied To Cataracts
Older men who opt for hormone-blocking therapy to treat prostate cancer might be slightly raising their risk of developing cataracts, hints new research.
FDA Issues Complete Response Letter to Alimera Sciences Regarding New Drug Application for ILUVIEN
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it received a Complete Response Letter (CRL) from the U.S. Food a…
Revised Glaucoma Guidance is Published
The Joint Group on NICE Glaucoma Guideline has published revised guidance clarifying the criteria for the referral of suspected glaucoma patients. Issued jointly by the College of Optometrists and the Royal College of Ophthalmologists, the updated ad…
Alternative Anti-VEGF Treatment Regimens in Exudative Age-related Macular Degeneration
This review explores the most current treatments for exudative age-related macular degeneration, including combination therapies. Expert Review of Ophthalmology
With Cataracts, Misinformation Seems To Abound
When medical experts talk about prevalence, they’re usually referring to how common a particular disease might be. But in the case of cataracts, they might just as well be talking about how common it is to uncover misinformation and misunderstanding ab…
Uncontrolled Hypertension, Chronic Kidney Disease May Increase Retinopathy Risk
High blood pressure and chronic kidney disease are associated with a higher incidence of retinopathy in subjects who are not diabetic, a study found.
American Academy Of Ophthalmology Responds To Genentech Rebate Program For Lucentis Use
Genentech (Hoffman – La Roche) manufactures two critically important pharmaceuticals, Lucentis and Avastin, which are both used for treatment of several common eye diseases – including age-related macular degeneration (AMD).
With Cataracts, Misinformation Seems To Abound
When medical experts talk about prevalence, they’re usually referring to how common a particular disease might be. But in the case of cataracts, they might just as well be talking about how common it is to uncover misinformation and misunderstanding ab…
PSivida Corp (PSDV) Says FDA Can’t Clear Diabetic Macular Edema Drug; Seeks Further Data On Alimera Sciences (ALIM)’ Iluvien
pSivida Corp. (NASDAQ:PSDV)(ASX:PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, including the investigational drug ILUVIEN® for the treatment of Diabetic Macular Edema (DME), today anno…